AmplifyMD’s $20M Series B fuels platform for scalable virtual specialty care.

We spend $1 of every $5 in the U.S. economy on healthcare. That’s exorbitant compared to most developed countries, where people live longer than we do at half the cost. Perverse incentives continue to drive unsustainable cost growth, with employer plans expected to grow by more than 9% in 2026. Our current model reduces employee take-home pay and saddles future generations with added debts to pay for today’s inefficient, fragmented system.

We need startups to clean up this unmanageable mess. To disrupt the current system, entrepreneurs must challenge health oligopolies (e.g., insurance carriers, PBMs, health systems) and chip away at the economic rent extracted by overpaid intermediaries (e.g., brokers, provider contractors, revenue cycle vendors). They also must build new platforms to enable efficient care delivery, powered by AI.

Provider shortages abound because the medical profession has long operated under an oligopoly and guild mentality, limiting the number of new physicians trained each year. Fortunately, technology now allows vastly more efficient distribution of provider time and talent, which could ultimately reverse the expected scarcity. The pandemic proved that care can be delivered effectively in virtual settings, despite primitive tools. As data has also become more portable, we may finally see the end of an era where provider systems hoard data to keep patients in high-cost settings and preserve unfair pricing power. Advances in software now allow “systems of engagement” to interface seamlessly with legacy “systems of record.” This opens the door to disrupting EHR monoliths and creating “new moats,” with AI poised to inject powerful new capabilities into outdated infrastructure.

These shifts create fertile ground for new platforms built for a digital-first, data-rich era, representing a new digital care architecture. AmplifyMD is one such platform – and today we’re thrilled to announce its $20M Series B financing. As an AmplifyMD director, I’ve seen firsthand how its EHR-integrated, AI-enabled virtual care platform helps health systems extend scarce physician capacity and drive material operational efficiencies. AmplifyMD allows specialists to practice anywhere, virtually treating patients in acute care settings and beyond, via its state-of-the-art platform. What began as a solution to expand specialist access in underserved settings has become a systemwide coverage solution trusted by some of the nation’s largest health systems—enabling physicians to extend their expertise without geographic limits.

The age of AI will further transform AmplifyMD’s product into an essential aspect of efficient and effective care delivery. The advent of superintelligent AI in medicine presents a golden opportunity for “creative destruction” to take root, but its potential requires modern platforms like AmplifyMD, which shift workflows from the in-person setting to always-on digital infrastructure. AI can enhance productivity and quality through clinical decision support today, and over time, may enable increasingly autonomous care delivery. This will give patients a greater ability to participate in decisions while receiving tailored treatment plans.

In the modern architecture of care delivery, AI agents will likely evolve to do the heavy lifting for all of us, freeing providers to focus on the highest leverage moments. With innovations like AmplifyMD’s platform, powered by this new financing, the industry can move toward greater access to high-quality care – an important step toward a system that respects our limits today while unlocking our innovative potential for tomorrow.